NVAX Cost of Revenue
Novavax Inc · Cost of Revenue
NVAX Cost of Revenue
Latest reported$91.64Mperiod ending
NVAX Cost of Revenue (-$300.00K → $91.64M)
Annual cost of revenue
High-resolution chart · PNG
NVAX cost of revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 71,140,000 | |
| 202,739,000 | |
| 343,768,000 | |
| 902,639,000 | |
| 0 | |
| 0 | |
| 113,842,000 | |
| 0 | |
| 0 | |
| 237,939,000 | |
| 162,644,000 | |
| 14,987,000 | |
| 8,222,000 | |
| 14,692,000 | |
| 7,003,000 | |
| 0 | |
| 0 | |
| 0 | |
| 221,000 | |
| 6,473,000 | |
| 5,791,000 | |
| 3,490,000 | |
| 2,057,000 | |
| 3,559,000 | |
| 4,052,000 | |
| -594,000 | |
| -400,000 | |
| -300,000 | |
| -300,000 | |
| -300,000 |